Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

NCT05084872 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Mastocytosis

Interventions

DRUG: Hydroxychloroquine

Sponsor

University Hospital, Toulouse